During a sometimes contentious confirmation hearing, Robert F. Kennedy Jr. refused to confirm that he believes vaccines do not cause autism.

AI in drug development is a vague term that might mean many things, and today, Owkin is announcing it has enrolled the first patient in a phase 1 study of OKN4395, its “AI-optimized” candidate for ...

RFK Jr.'s confirmation hearings continue today as he appears before a second Senate committee. Follow STAT's live updates.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, today we look at ...

In his first confirmation hearing, Robert F. Kennedy Jr. tried to distance himself from his past statements on abortion and ...

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning! It's Thursday. Friday ...

Ugandan health officials on Thursday confirmed a case of Ebola in the capital Kampala, in a nurse who sought care at a number ...

Christophe Weber will step down as CEO of Takeda next year, the company announced, following a dropoff in its share price ...

Akero's success in reversing cirrhosis follows that of Madrigal, making analysts and investors bullish on drugs to treat ...

Trump's executive orders seem to be part of a plan to leverage NIH and other grants to force universities to end DEI programs ...

Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process more efficient.

In 2000, in response to the frustration of 23 million California HMO consumers, I was appointed by then-California Gov. Gray Davis to be the nation’s first “HMO czar.” The new agency I was running was ...